Evidence map›Paper›PMID 21985128›Full record

ArticleBMC psychiatry2011

Sub-threshold depression and antidepressants use in a community sample: searching anxiety and finding bipolar disorder.

Mauro G Carta, Leonardo Tondo, Matteo Balestrieri, Filippo Caraci, Liliana Dell'osso, Guido Di Sciascio, Carlo Faravelli, Maria Carolina Hardoy, Maria E Lecca, Maria Francesca Moro and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Measurement properties of tools used to assess depression in adults with and without autism spectrum conditions: A systematic review.Autism research : official journal of the International Society for Autism Research · 2018
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Design of FRET Probes for SNP RS1006737, Related to Mood Disorder.Clinical practice and epidemiology in mental health : CP & EMH · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 3 countries.

Mauro G CartaDepartment of Public Health, University of Cagliari, Cagliari, Italy. mgcarta@tiscali.it
Leonardo Tondo
Matteo Balestrieri
Filippo Caraci
Liliana Dell'osso
Guido Di Sciascio
Carlo Faravelli
Maria Carolina Hardoy
Maria E Lecca
Maria Francesca Moro
Krishna M Bhat
Massimo Casacchia
Filippo Drago
University of Cagliari · ITUniversity of Catania · ITHarvard University · USThe University of Texas Medical Branch at Galveston · USUniversity of Bari Aldo Moro · ITUniversity of Florence · ITUniversity of L'Aquila · ITUniversity of Pisa · ITUniversity of Udine · ITUniversity of Vlora "Ismail Qemali" · AL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo determine the use of antidepressants (ADs) in people with sub-threshold depression (SD); the lifetime prevalence of mania and hypomania in SD and the link between ADs use, bipolarity and anxiety disorders in SD.

methodsSTUDY

designcommunity survey. STUDY POPULATION: samples randomly drawn, after stratification from the adult population of municipal records. SAMPLE SIZE: 4999 people from seven areas within six Italian regions. Tools: Questionnaire on psychotropic drug consumption, prescription; Structured Clinical Interview NP for DSM-IV modified (ANTAS); Hamilton Depression Rating Scale (HAM-D); Mood Disorder Questionnaire (MDQ); Short Form Health Survey (SF-12). SD definition: HAM-D > 10 without lifetime diagnosis of Depressive Episode (DE).

resultsSD point prevalence is 5.0%. The lifetime prevalence of mania and hypomania episodes in SD is 7.3%. Benzodiazepines (BDZ) consumption in SD is 24.1%, followed by ADs (19.7%). In SD, positive for MDQ and comorbidity with Panic Disorder (PD) or Generalized Anxiety Disorders (GAD) are associated with ADs use, whereas the association between a positive MDQ and ADs use, without a diagnosis of PD or GAD, is not significant. Only in people with DE the well-being (SF-12) is higher among those using first-line antidepressants compared to those not using any medication. In people with SD no significant differences were found in terms of SF-12 score according to drug use.

conclusionsThis study suggests caution in prescribing ADs to people with SD. In people with concomitant anxiety disorders and SD, it should be mandatory to perform a well-designed assessment and evaluate the presence of previous manic or hypomanic symptoms prior to prescribing ADs.

Indexed as

AdolescentAdultAgedAntidepressive AgentsAnxiety DisordersBenzodiazepinesBipolar DisorderDepressionFemaleHealth SurveysHumansItalyMaleMiddle AgedPrevalencePsychiatric Status Rating ScalesAntidepressive AgentsBenzodiazepines

Identifiers

PMID21985128
PMCPMC3206417
OpenAlexW2015568745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.